Jenny Nachbar

Jenny Nachbar has a diverse work experience spanning various industries. Jenny is currently the Director of Safety Sciences and Surveillance at Novavax Inc, where they oversee safety-related activities. Prior to this, they worked as an Associate Director of Safety Surveillance at the same company.

Before joining Novavax Inc, Jenny was employed at Synergy Research Inc. for several years. Jenny held the position of Senior Manager of Pharmacovigilance, where they led a team and was responsible for drafting regulatory documents and reviewing clinical data for safety signals. Jenny also worked as a Clinical Scientist, drafting adverse event narratives and managing a safety database.

Jenny also has experience in the field of research and development. Jenny worked at Sideromics as the Director of Research Programs and as a Pharmaceutical R&D Scientist. Additionally, they have worked as a Contract Editor at AJE - American Journal Experts, a Content Developer at the Institute for Wellness Education, and a Freelance Editor at Sirius Interactive.

Overall, Jenny Nachbar has a strong background in safety sciences, pharmacovigilance, research, and editorial roles.

Jenny Nachbar has a PhD in Biomedical Sciences with a specialization in Cell Biology from Albert Einstein College of Medicine, which they completed between 2004 and 2013. Prior to that, they obtained an MA in Biotechnology from Columbia University in 2004. Jenny'sundergraduate degree, a BA in Biology, was earned from Yeshiva University from 1999 to 2003. Jenny has also obtained various certifications, including Pharmacoepidemiology I and II from McGill University in 2022, Conflicts of Interest from the CITI Program in 2021, GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus) from the CITI Program in 2021, and Basics of Signal Detection and Pharmacoepidemiology from DRUG INFORMATION ASSOCIATION (DIA) in 2020.